Fresenius Medical Care AG & Co. KGaA (FMS) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Fresenius Medical Care AG... (FMS)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

22.64

0.30 (1.34%)

At close: Jan 14, 2025, 3:59 PM

22.59

-0.24%

Pre-market Jan 15, 2025, 06:00 AM EST

undefined% (undefined)

Bid	22.62
Market Cap	13.29B
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	1.15
PE Ratio (ttm)	19.69
Forward PE	n/a
Analyst	Hold

Ask	22.66
Volume	357,220
Avg. Volume (20D)	265,739
Open	22.21
Previous Close	22.34
Day's Range	22.14 - 22.69
52-Week Range	17.93 - 24.31
Beta	undefined

About FMS

Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and di...

[Show more]

Industry Medical - Care Facilities

Sector Healthcare

IPO Date Sep 17, 1996

Employees 113,079

Stock Exchange NYSE

Ticker Symbol FMS

Website https://www.freseniusmedicalcare.com

Analyst Forecast

According to 1 analyst ratings, the average rating for FMS stock is "Hold." The 12-month stock price forecast is $25, which is an increase of 10.40% from the latest price.

Buy 0.00%

Hold 100.00%

Sell 0.00%

Stock Forecasts

Next Earnings Release

Fresenius Medical Care AG & Co. KGaA is scheduled to release its earnings on Feb 25, 2025, before market opens.
Analysts project revenue of $5.62B, reflecting a 4.67% YoY growth and earnings per share of 0.39, making a -17.72% decrease YoY.

Why Price Moved

5 months ago · Source

-3.59%

Fresenius Medical Care shares are trading lower af... Unlock content with Pro Subscription

6 months ago · Source

-2.26%

DaVita and Fresenius shares are trading lower following a report suggesting the FTC is investigating the companies.

News

1 week ago · zacks.com

Fresenius (FMS) Upgraded to Strong Buy: Here's What You Should Know

Fresenius (FMS) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

1 week ago · zacks.com

Best Income Stocks to Buy for January 7th

PRMB, FMS and RBA made it to the Zacks Rank #1 (Strong Buy) income stocks list on January 7, 2024.

1 week ago · zacks.com

Best Value Stocks to Buy for January 7th

FMS, SVM and CNO made it to the Zacks Rank #1 (Strong Buy) value stocks list on January 7, 2024.

2 weeks ago · zacks.com

Best Momentum Stocks to Buy for December 27th

PAYO, TTDKY and FMS made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on December 27, 2024.

2 weeks ago · zacks.com

Best Income Stocks to Buy for December 27th

TTDKY, FMS and FHB made it to the Zacks Rank #1 (Strong Buy) income stocks list on December 27, 2024.

2 weeks ago · zacks.com

Best Value Stocks to Buy for December 27th

AAL, FMS and TTDKY made it to the Zacks Rank #1 (Strong Buy) value stocks list on December 27, 2024.

4 weeks ago · zacks.com

4 Value Stocks to Buy as Wall Street Awaits Fed's Rate Decision

Value investing is essentially about selecting stocks that are usually cheap but fundamentally sound. TSN, GM, FMS and DLX boast a low P/CF ratio.

4 weeks ago · zacks.com

5 Low Price-to-Book Value Stocks to Buy as 2024 Draws to a Close

The P/B ratio helps to identify low-priced stocks with high growth prospects. GM, FMS, CIO, TRTX and ZIM are some such stocks.

4 weeks ago · zacks.com

Leadership in Dialysis Services and Products Drives FMS Stock

Fresenius Medical Care leads global dialysis services, driving growth through innovation, restructuring and a strong global footprint in 120+ countries.

1 month ago · zacks.com

Are Investors Undervaluing Fresenius Medical Care AG & Co. (FMS) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...

1 month ago · zacks.com

Here's Why Fresenius (FMS) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

2 months ago · zacks.com

Why Fresenius (FMS) is a Top Value Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

2 months ago · zacks.com

Is Fresenius Medical Care AG & Co. (FMS) Stock Undervalued Right Now?

2 months ago · zacks.com

Fresenius Medical Q3 Earnings Beat Estimates, Operating Margin Rises

FMS' third-quarter results showcase a strong segmental performance. The company raises its full-year 2024 outlook for operating income.

2 months ago · zacks.com

Fresenius (FMS) is a Top-Ranked Momentum Stock: Should You Buy?

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

2 months ago · youtube.com

Hard work paying off despite challenges from U.S. weather-related events: Fresenius Medical Care CEO

Helen Giza, the CEO of Fresenius Medical Care, discusses the German healthcare firm's third-quarter earnings.

2 months ago · seekingalpha.com

Fresenius Medical Care AG (FMS) Q3 2024 Earnings Call Transcript

Fresenius Medical Care AG (NYSE:FMS ) Q3 2024 Earnings Conference Call November 5, 2024 8:00 AM ET Company Participants Dominik Heger - Head, Investor Relations Helen Giza - Chief Executive Officer an...

2 months ago · zacks.com

Should Value Investors Buy Fresenius Medical Care AG & Co. (FMS) Stock?